![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plantic Tech. | LSE:PLNT | London | Ordinary Share | AU0000XINEG8 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.75 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPLNT RNS Number : 7909Q Plantic Technologies Limited 20 April 2009 20 APRIL 2009 PLANTIC TECHNOLOGIES LIMITED ("Plantic" or "the Company") Audited results for year ended 31 December 2008 Healthy cash position, strong customer engagement and improved operational base Plantic (AIM:PLNT), the technology company engaged in the development and commercialisation of a range of environmentally friendly plastics from renewable resources, today announces its results for the year ended 31 December 2008. The results are as released in the trading update dated 16 February 2009. Plantic's novel polymer manufacturing technology is based on the use of high-amylose corn starch, a material derived from annual harvesting of specialized (hybrid) corn. The unique chemical and film-forming properties of this type of cornstarch allow for development of a range of applications across conventional plastics markets. In addition to being renewably sourced, users can take advantage of excellent end-of-life properties such as biodegradability and compostability. Plantic has several patents covering its technologies, formulations and applications. The Company's objective is to commercialise its plastic technologies across a broad range of applications, with a particular focus on the packaging industry. Its "Plantic tray" is sold commercially in the UK, Continental Europe, Australia and New Zealand. Injection Moulding resins are sold via DuPont globally excluding Australia and New Zealand. HIGHLIGHTS OF 2008 * Closing cash position at 31 December 2008 was A$26.4m. * Net cash outflow reduced to A$4.5m in the second half of 2008 compared to A$7.9m for the same period in 2007, and A$7m in the first half of 2008. * Plantic's net loss for 2008 was A$9m (2007 A$10.3m), less than market expectations and lower than 2007, boosted by increased sales and favorable changes in exchange rates. The net loss in the second half of 2008 was $3.4m compared to A$5.8m for the same period in 2007 and A$5.6m in the first half of 2008. * Sales revenue increased to A$3.6m, 145% higher than 2007 (2007: A$1.5m). Second half sales were A$2.8m, 295% higher than the same period in 2007. * Sales volumes (in metric tonnes) increased by 120% for the full year of 2008 compared to 2007. * Sales volumes (in metric tonnes) increased by 170% in the second half of 2008, compared to the same period in 2007, and 120% compared to the first half of 2008. * Plantic's first stage investment in the manufacturing plant in Jena in Germany has been completed on time and budget and has led to increased customer interest in Europe. German government subsidies of approximately A$1m are expected to be received during the course of 2009 as a result of this investment by the company. Brendan Morris, Plantic's Chief Executive, commented: "The global economic environment has continued to deteriorate. This is having an effect on Plantic's growth and performance in 2009. However, the Directors remain confident about the long-term prospects for the company and its technology. Plantic's strong cash reserves, improvements in plant capacity in Australia and our new production facilities in Europe provide a platform to continue to develop and improve products during this period of economic downturn." FURTHER INFORMATION: +-------------------------------------+-------------------------------------+ | Plantic Technologies: | | +-------------------------------------+-------------------------------------+ | Brendan Morris, Chief Executive | +61(0)3 9353 7983 | | Officer | | +-------------------------------------+-------------------------------------+ | | | +-------------------------------------+-------------------------------------+ | Nomura Code Securities Limited: | | +-------------------------------------+-------------------------------------+ | Juliet Thompson | +44 (0)20 7776 1204 | +-------------------------------------+-------------------------------------+ | | | +-------------------------------------+-------------------------------------+ | Pelham PR: | | +-------------------------------------+-------------------------------------+ | Archie Berens | +44 (0)207 337 1509 / +44 (0)7802 | | | 442486 | +-------------------------------------+-------------------------------------+ Chairman's Report 2008 It is indeed challenging in the current environment to provide shareholders and other interested parties with a clear view of the near term future. For Plantic, however, the positives are: * We are one of the few true bioplastics companies that has been selling sheet for thermoforming for many years in Australia and Europe. We continue to develop new products for higher strength thermoforming applications as well as for other markets including injection moulding and flexible packaging. * At 31 December, 2008, we have A$26.4M cash from our equity raising in 2007 which will continue to support our progress as we build sales of existing and new products toward break even and profit. * With our new Jena (East Germany) investment in thermoforming, by the end of 2008 we will have replicated in Europe our successful Australian strategy enabling Plantic to supply thermoformed trays and other forms to key brand owners, thus facilitating conversion from PET, PP, PE, etc. to Plantic material. This investment is critical to our planned market expansion in Continental Europe and in the UK. The addition of extrusion facilities at a later date will provide additional sheet and resin production capacity at lower costs. * Our very active partnerships with global leaders DuPont, National Starch, Amcor, Bemis plus others (subject to confidentiality agreements) is welcomed by your board as an endorsement of the potential seen in Plantic by these companies. * Brand owners continue to demand progressively increased content of truly biodegradable and compostable material based on renewable raw materials in their packaging and other products. Plantic products eminently meet these criteria, as well as enjoying a lower energy "footprint" to many competitive products. * We have a relatively small, but highly experienced team of professionals in Australia, Europe and the USA ably led by our Chief Executive Officer, Mr Brendan Morris. The board believes this team has the capability to achieve the stretching strategic goals and annual targets set for Plantic. The board and management believe Plantic is well placed to cope with the highly volatile environment pervading the world economy. With our corn-based feedstock, we are resolved to remain competitive with petrochemical-derived plastics such as PET, recycled-PET, PP, PE, etc., even with crude oil prices suddenly becoming so volatile. We also believe we are very competitive with current and newer bioplastics. To reach desired profit levels, we need to achieve our projected increased sales volumes and fully utilise our current and planned additional production capacity. Worthy of special mention is the high level of support, technical and commercial, from our key, specialised corn starch supplier, National Starch (USA). They, like us, see true plastics made from this annual, non-GM crop based on Plantic's technology, as one of the leading environmentally friendly, "green" materials of the future. In summary, Plantic is well placed, financially and commercially, to continue its growth by completing successfully the many current and planned development projects with key brand owners in Europe, North and South America, Australia and Asia, in conjunction with our partners. We have acted positively to meet the need for additional lower cost production capacity in Europe. The board acknowledge the support of our many shareholders who clearly share our view of the potential for Plantic Technologies Ltd, even in the face of the extremes we have seen with stock prices over the last year. OPERATING AND FINANCIAL REVIEW Commercial Development Sales of Plantic products increased by 145% over 2007, with the second half of 2008 being 295% higher than the same period in 2007 and 250% higher than the first half. This sales growth was on the back of the DuPont distribution agreement and the initial stocking orders for Plantic products. During 2008 DuPont extended their distribution agreement for our sheet products to include South America and Japan, two important growth markets for Plantic products and we have already seen strong interest from those markets. Plantic products during 2008 were used commercially by major brand owners, including Cadbury, Lindt, Marks and Spencer and Sainsbury's to name a few. Trials by global brand owners progressed during 2008 and we expect further adoptions of Plantic materials in 2009 in a range of new applications including confectionery, biscuits and industrial products. Future growth is expected to benefit substantially from Plantic's broader market access via DuPont and our increased manufacturing capability in Germany. Plantic has strengthened its sales resources in Europe and the USA to support sales growth and brand owners' marketing. This, coupled with our investment in Thermoforming capability in Jena, has resulted in increased interest for Plantic products. Plantic's Jena facility became operational in February 2009, on time and within budget. The first small product orders have now been received for the Jena facility. Product Development Plantic's intellectual property portfolio was further strengthened in 2008, with the granting of our second and third US patents supporting our core High Amylose Starch Technology. In addition, our relationship with DuPont produced additional Plantic IP, with a patent for our products including DuPont's modifiers to expand the properties of Plantic products. The work with Bemis and Amcor (global leaders in flexible packaging) continued to progress well, with both partners running Plantic based products on their production lines. Both partners have identified significant commercial opportunities for Plantic resins, which could deliver significant revenues for Plantic in the future. Plantic also launched its new High Performance Sheet product at Interpack (Europe's largest packaging exhibition). Plantic's new high performance sheet grade - Plantic HP1 - is a new development in biodegradable packaging. It enhances the existing functional properties of Plantic R1 sheet, thereby creating new market opportunities. This new grade offers higher impact resistance and clarity, required for blister and clamshell packaging where the products inside need to be showcased. Plantic's products continued to be recognised by industry. In 2008 it won the Australian Plastics and Chemical Industry Association award for sustainability; and the use of Plantic packaging by Marks and Spencer secured one of the 20th DuPont Global Awards for Packaging Innovation. Operations Plantic completed its triennial audit of the ISO 9001 system, resulting in our accreditation being recertified. The focus on quality continues to be high and resulted in all our quality indicators improving in 2008. Operational performance also improved in 2008. Significant investment was made in new plant and equipment designed to improve the quality of Plantic products as well as the output and efficiency of the production process. Whilst the commissioning of this new equipment and the resin line impacted negatively on our manufacturing efficiencies and output during 2008, they delivered a 300% increase in demonstrated capacity at the end of 2008. Plantic enters 2009 with improved manufacturing processes and quality and the focus in 2009 is to cement these improvements and drive the efficiency gains which will be reflected in reduced cost of sales. In addition, Plantic was able to convert its sheet extrusion line into a multipurpose production line making both sheet and resin products. This provides greater manufacturing flexibility in our plant in Australia. OUTLOOK The global economic environment has deteriorated significantly. This will be likely to slow Plantic's growth in 2009 as customers focus internally on restructure and cost reduction. However, the Directors remain confident about the long-term prospects for the company and its technology. Plantic's strong cash reserves, improvements in plant capacity in Australia and our new production facilities in Europe provide a platform to continue to develop and improve products and work with our current and prospective customers despite this period of economic downturn. ENVIRONMENTAL REGULATION AND PERFORMANCE A Life Cycle Assessment (LCA) of Plantic rigid trays from cradle to grave was first conducted in August 2004 (James and Grant 2004) and was recently updated in December 2008 to incorporate the process changes implemented to Plantic's production line since that 2004. This updated 2008 LCA indicates that when compared to other conventional petrochemical-based polymers used in similar tray applications, 42% less energy is required to produce the equivalent number of Plantic trays. Additionally, Plantic materials are estimated to have 45-70% lower impact on global warming than other polymers (PVC, PET, PE, PP, GPPS), when composted. Based on these results, for every tonne of Plantic sheet purchased in place of petrochemical polymers, 1.25-2.5 tonnes of carbon dioxide will be saved when composted (equivalent to the average annual emissions of a small car) and enough energy saved to power 2.5 average Australian homes for a year. The LCA underscores the outstanding environmental performance of Plantic materials and is particularly relevant in a world that is facing the challenge of climate change and diminishing fossil fuels. Plantic Technologies' operations are not regulated by any significant environmental regulation under a law of the Commonwealth or of a State or Territory. Plantic has not had any environmental issues during the period and is in compliance with the applicable laws and regulations. SIGNIFICANT CHANGES IN THE STATE OF AFFAIRS Plantic has completed its investment in the Jena facility (Eastern Germany) with the addition of thermoforming manufacturing capability. This operation will allow for rapid prototyping, more efficient customer trials, and increased production capacity. This will accelerate Plantic's entry into the European thermoforming market and, most importantly, further improve Plantic's competitiveness and response to customers and brand owners. Once sufficient thermoforming volume is established, based on imported sheet, it is planned that a second phase of the strategy will be implemented by installing rigid sheet production. This strategy will eliminate sea freight, thereby streamlining the supply chain and, ultimately, lowering Plantic's production costs. Extruded Plantic materials will not only be utilized by Plantic's thermoforming business, but also by third party thermoformers and converters. Income Statement for the year ended 31 December 2008 +-----------+----------+-----------------------------+------+---------------+---------------+ | | | | | CONSOLIDATED | +-----------+----------+-----------------------------+------+-------------------------------+ | | | | | 12 | 12 | | | | | | months | months | +-----------+----------+-----------------------------+------+---------------+---------------+ | | | | | 31/12/2008 | 31/12/2007 | +-----------+----------+-----------------------------+------+---------------+---------------+ | | | | | $ | $ | +-----------+----------+-----------------------------+------+---------------+---------------+ | Sales revenue | | 3,557,816 | 1,489,168 | +----------------------------------------------------+------+---------------+---------------+ | Government grants | | 74,174 | 470,313 | +----------------------------------------------------+------+---------------+---------------+ | Cost of sales | | (3,577,004) | (1,806,987) | +----------------------------------------------------+------+---------------+---------------+ | Engineering and manufacturing scale up costs | | (3,089,907) | (2,314,618) | +----------------------------------------------------+------+---------------+---------------+ | Gross Profit | | (3,034,921) | (2,162,124) | +----------------------------------------------------+------+---------------+---------------+ | Finance revenue | | 2,021,318 | 1,839,304 | +----------------------------------------------------+------+---------------+---------------+ | Other income | | 1,032,928 | - | +----------------------------------------------------+------+---------------+---------------+ | Other expenses | | - | (620,713) | +----------------------------------------------------+------+---------------+---------------+ | Administrative expenses | | (3,029,594) | (2,454,898) | +----------------------------------------------------+------+---------------+---------------+ | Selling Expenses | | (2,034,513) | (1,574,213) | +----------------------------------------------------+------+---------------+---------------+ | Research and development expenses | | (2,767,086) | (3,616,715) | +----------------------------------------------------+------+---------------+---------------+ | Share based payment expense | | (882,473) | (1,033,008) | +----------------------------------------------------+------+---------------+---------------+ | Loss before income tax and finance costs | | (8,694,341) | (9,622,367) | +----------------------------------------------------+------+---------------+---------------+ | Finance costs | | (260,626) | (644,024) | +----------------------------------------------------+------+---------------+---------------+ | Loss before income tax | | (8,954,967) | (10,266,391) | +----------------------------------------------------+------+---------------+---------------+ | Income tax | | - | - | +----------------------------------------------------+------+---------------+---------------+ | Net loss | | (8,954,967) | (10,266,391) | +----------------------------------------------------+------+---------------+---------------+ | | | | | | | +-----------+----------+-----------------------------+------+---------------+---------------+ | | | | | Cents | Cents | +-----------+----------+-----------------------------+------+---------------+---------------+ | Loss per share for loss attributable to the ordinary | | | | equity holders of the company: | | | + +---------------+---------------+ | | | | +-----------------------------------------------------------+---------------+---------------+ | Basic loss per share | | (11.23) | (16.16) | +----------------------------------------------------+------+---------------+---------------+ | Diluted loss per share | | (11.23) | (16.16) | +-----------+----------+-----------------------------+------+---------------+---------------+ Balance Sheet as at 31 December 2008 +---+--+----------------------+------+----------------+----------------+ | | | | | CONSOLIDATED | +---+--+----------------------+------+---------------------------------+ | | | | | 12 months | 12 | | | | | | | months | +---+--+----------------------+------+----------------+----------------+ | | | | | 31/12/2008 | 31/12/2007 | +---+--+----------------------+------+----------------+----------------+ | | | | | $ | $ | +---+--+----------------------+------+----------------+----------------+ | Assets | | | | +-----------------------------+------+----------------+----------------+ | Cash and cash equivalents | | 26,400,386 | 38,002,376 | +-----------------------------+------+----------------+----------------+ | Trade and other receivables | | 2,108,158 | 1,652,400 | | | | | | +-----------------------------+------+----------------+----------------+ | Inventories | | 3,865,580 | 3,294,014 | +-----------------------------+------+----------------+----------------+ | Other current assets | | 835,080 | 524,295 | +-----------------------------+------+----------------+----------------+ | Total Current Assets | | 33,209,204 | 43,473,085 | +-----------------------------+------+----------------+----------------+ | Plant and equipment | | 12,133,610 | 8,034,931 | +-----------------------------+------+----------------+----------------+ | Total Non-current Assets | | 12,133,610 | 8,034,931 | +-----------------------------+------+----------------+----------------+ | Total Assets | | 45,342,814 | 51,508,016 | +-----------------------------+------+----------------+----------------+ | | | | | | | +---+--+----------------------+------+----------------+----------------+ | Liabilities | | | | +-----------------------------+------+----------------+----------------+ | Trade and other payables | | 2,168,237 | 1,719,035 | +-----------------------------+------+----------------+----------------+ | Interest bearing | | 2,604,318 | 706,760 | | liabilities | | | | +-----------------------------+------+----------------+----------------+ | Provisions | | 143,951 | 308,699 | +-----------------------------+------+----------------+----------------+ | Total Current Liabilities | | 4,916,506 | 2,734,494 | +-----------------------------+------+----------------+----------------+ | Interest bearing | | 2,234,797 | 3,047,605 | | liabilities | | | | +-----------------------------+------+----------------+----------------+ | Provisions | | 38,428 | 23,814 | +-----------------------------+------+----------------+----------------+ | Total Non-current | | 2,273,225 | 3,071,419 | | Liabilities | | | | +-----------------------------+------+----------------+----------------+ | Total Liabilities | | 7,189,731 | 5,805,913 | +-----------------------------+------+----------------+----------------+ | Net Assets | | 38,153,083 | 45,702,103 | +-----------------------------+------+----------------+----------------+ | | | | | | | +---+--+----------------------+------+----------------+----------------+ | Equity | | | | +-----------------------------+------+----------------+----------------+ | Issued capital | | 76,314,128 | 76,261,380 | +-----------------------------+------+----------------+----------------+ | Reserves | | 2,299,157 | 1,014,533 | +-----------------------------+------+----------------+----------------+ | Accumulated Losses | | (40,460,202) | (31,573,810) | +-----------------------------+------+----------------+----------------+ | Total Equity | | 38,153,083 | 45,702,103 | +-----------------------------+------+----------------+----------------+ | | | | | | | +---+--+----------------------+------+----------------+----------------+ Cash Flow Statement for the year ended 31 December 2008 +-------------------------+--+------------------------+--------+--------------+--------------+ | | | | | CONSOLIDATED | +-------------------------+--+------------------------+--------+-----------------------------+ | | | | | 12 | 12 | | | | | | months | months | +-------------------------+--+------------------------+--------+--------------+--------------+ | | | | | 31/12/2008 | 31/12/2007 | +-------------------------+--+------------------------+--------+--------------+--------------+ | | | | | $ | $ | +-------------------------+--+------------------------+--------+--------------+--------------+ | Cash flows used in operating activities | | | | +-----------------------------------------------------+--------+--------------+--------------+ | Receipts from customers and related parties | | 3,156,304 | 1,494,544 | +-----------------------------------------------------+--------+--------------+--------------+ | Grants received | | 74,174 | 387,400 | +-----------------------------------------------------+--------+--------------+--------------+ | Payments to suppliers and employees | | (14,107,628) | (12,771,695) | +-----------------------------------------------------+--------+--------------+--------------+ | Net cash flows used in operating activities | | (10,877,150) | (10,889,751) | +-----------------------------------------------------+--------+--------------+--------------+ | Cash flows used in | | | | | | | investing activities | | | | | | +-------------------------+--+------------------------+--------+--------------+--------------+ | Purchase of property, plant and equipment | | (526,153) | (1,267,908) | +-----------------------------------------------------+--------+--------------+--------------+ | Payment for plant under construction | | (4,310,203) | - | +-----------------------------------------------------+--------+--------------+--------------+ | | | | | | | +-------------------------+--+------------------------+--------+--------------+--------------+ | Net cash flows used in investing activities | | (4,836,356) | (1,267,908) | +-----------------------------------------------------+--------+--------------+--------------+ | Cash flows from financing activities | | | | +-----------------------------------------------------+--------+--------------+--------------+ | Interest paid | | (260,626) | (310,329) | +-----------------------------------------------------+--------+--------------+--------------+ | Interest received | | 3,124,694 | 881,816 | +-----------------------------------------------------+--------+--------------+--------------+ | Repayment of finance lease borrowings | | (715,250) | (674,172) | +-----------------------------------------------------+--------+--------------+--------------+ | Proceeds from bank borrowings | | 1,800,000 | - | +-----------------------------------------------------+--------+--------------+--------------+ | Proceeds from issue of shares | | - | 48,352,123 | +-----------------------------------------------------+--------+--------------+--------------+ | Payments of share issue costs | | - | (4,309,263) | +-----------------------------------------------------+--------+--------------+--------------+ | Net cash flows from financing activities | | 3,948,818 | 43,940,175 | +-----------------------------------------------------+--------+--------------+--------------+ | Net increase/(decrease) in cash and cash equivalents | (11,764,688) | 31,782,516 | +--------------------------------------------------------------+--------------+--------------+ | | | | | | | +-------------------------+--+------------------------+--------+--------------+--------------+ | Cash and cash equivalents | | | | +-----------------------------------------------------+--------+--------------+--------------+ | | - net foreign exchange | | 162,698 | (32,244) | | | differences | | | | +-------------------------+---------------------------+--------+--------------+--------------+ | Cash and cash equivalents | | | | +-----------------------------------------------------+--------+--------------+--------------+ | | - at beginning of the | | 38,002,376 | 6,252,104 | | | year | | | | +-------------------------+---------------------------+--------+--------------+--------------+ | | - at end of the year | | 26,400,386 | 38,002,376 | +-------------------------+--+------------------------+--------+--------------+--------------+ Statement of Changes in Equity for the year ended 31 December 2008 +---+--+---------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | | | | Other | Share | Issued | Foreign | Accumulated | Total | | | | | reserves | based | Capital | currency | losses | | | | | | | payments | |translation | | | | | | | | reserve | | reserve | | | +---+--+---------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | CONSOLIDATED | $ | $ | $ | $ | $ | $ | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Balance at | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | 1 January 2007 | 100,134 | 172,508 | 21,520,977 | (158,739) | (21,307,419) | 327,461 | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Foreign currency | - | - | - | (32,243) | - | (32,243) | | translation | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Total income and | - | - | - | (32,243) | - | (32,243) | | expense for the period | | | | | | | | recognised directly in | | | | | | | | equity | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Net loss for the period | - | - | - | - | (10,266,391) | (10,266,391) | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Total income and | - | - | - | (32,243) | (10,266,391) | (10,298,634) | | expense for the period | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | | | | | | | | | | +---+--+---------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | EquityTransactions: | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Share Based Payment | - | 1,033,007 | - | - | - | 1,033,007 | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Conversion of convertible | (100,134) | - | 10,697,543 | - | - | 10,597,409 | | notes | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Increase in share capital | - | - | 48,352,123 | - | - | 48,352,123 | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Less transaction costs | - | - | (4,309,263) | - | - | (4,309,263) | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Balance at | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | 31 December 2007 | - | 1,205,515 | 76,261,380 | (190,982) | (31,573,810) | 45,702,103 | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | | | | | | | | | | +---+--+---------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Balance at | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | 1 January 2008 | - | 1,205,515 | 76,261,380 | (190,982) | (31,573,810) | 45,702,103 | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Foreign currency | - | - | - | 523,474 | - | 523,474 | | translation | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Total income and | - | - | - | 523,474 | - | 523,474 | | expense for the period | | | | | | | | recognised directly in | | | | | | | | equity | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Net loss for the period | - | - | - | - | (8,954,967) | (8,954,967) | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Total income and | - | - | - | 523,474 | (8,954,967) | (8,431,493) | | expense for the period | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | | | | | | | | | | +---+--+---------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | EquityTransactions: | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Share Based Payment | - | 882,473 | - | - | - | 882,473 | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Vested options not being | - | (68,575) | - | | 68,575 | - | | exercised | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Increase in issued capital | - | (52,748) | 52,748 | - | - | - | | | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | | | | | | | | | | +---+--+---------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | Balance at | | | | | | | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | 31 December 2008 | - | 1,966,665 | 76,314,128 | 332,492 | (40,460,202) | 38,153,083 | +----------------------------+-------------+-------------+---------------+-------------+----------------+---------------+ | | | | | | | | | | +---+--+---------------------+-------------+-------------+---------------+-------------+----------------+---------------+ The Directors do not recommend the payment of a dividend. The full annual Report will be posted to shareholders on 30th April 2008 and will also be available on the Company's website www.plantic.com.au. Copies will be available from that date from the Company's office, 51 Burns Road, Altona, VIC, 3018, Australia and from the offices of Pelham Public Relations, No. 1 Cornhill, London EC3V 3ND, United Kingdom. This information is provided by RNS The company news service from the London Stock Exchange END FR SFSFMWSUSESL
1 Year Plantic Technologies Chart |
1 Month Plantic Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions